Free Trial

Mannatech (MTEX) Competitors

Mannatech logo
$8.06 -0.28 (-3.30%)
Closing price 07/25/2025 03:57 PM Eastern
Extended Trading
$8.38 +0.33 (+4.08%)
As of 07/25/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MTEX vs. PYRGF, ATRA, KLTO, ARTV, IFRX, ADVM, IZTC, INMB, ABVC, and ALGS

Should you be buying Mannatech stock or one of its competitors? The main competitors of Mannatech include PyroGenesis Canada (PYRGF), Atara Biotherapeutics (ATRA), Klotho Neurosciences (KLTO), Artiva Biotherapeutics (ARTV), InflaRx (IFRX), Adverum Biotechnologies (ADVM), Invizyne Technologies (IZTC), INmune Bio (INMB), ABVC BioPharma (ABVC), and Aligos Therapeutics (ALGS). These companies are all part of the "pharmaceutical products" industry.

Mannatech vs. Its Competitors

PyroGenesis Canada (NASDAQ:PYRGF) and Mannatech (NASDAQ:MTEX) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 13.0% of Mannatech shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by company insiders. Comparatively, 41.5% of Mannatech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Mannatech had 2 more articles in the media than PyroGenesis Canada. MarketBeat recorded 2 mentions for Mannatech and 0 mentions for PyroGenesis Canada. Mannatech's average media sentiment score of 0.93 beat PyroGenesis Canada's score of 0.00 indicating that Mannatech is being referred to more favorably in the news media.

Company Overall Sentiment
PyroGenesis Canada Neutral
Mannatech Positive

PyroGenesis Canada has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500.

Mannatech has higher revenue and earnings than PyroGenesis Canada. Mannatech is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PyroGenesis Canada$9.14M6.07-$21.12M-$0.02-14.80
Mannatech$117.87M0.13$2.49M-$0.10-80.55

Mannatech has a net margin of -0.19% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Mannatech's return on equity.

Company Net Margins Return on Equity Return on Assets
PyroGenesis Canada-115.14% N/A -60.81%
Mannatech -0.19%-2.56%-0.57%

Summary

Mannatech beats PyroGenesis Canada on 8 of the 13 factors compared between the two stocks.

Get Mannatech News Delivered to You Automatically

Sign up to receive the latest news and ratings for MTEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MTEX vs. The Competition

MetricMannatechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$15.84M$2.49B$5.69B$9.50B
Dividend YieldN/A1.65%4.58%4.01%
P/E Ratio-80.559.0528.1020.05
Price / Sales0.13612.51432.4490.07
Price / Cash3.90165.2136.2258.56
Price / Book1.765.168.665.87
Net Income$2.49M$30.99M$3.25B$258.55M
7 Day Performance2.87%7.74%4.23%3.74%
1 Month Performance-14.76%16.27%10.52%11.75%
1 Year Performance9.00%-1.88%34.41%18.03%

Mannatech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MTEX
Mannatech
1.0258 of 5 stars
$8.06
-3.3%
N/A+9.0%$15.84M$117.87M-80.55250News Coverage
Gap Up
PYRGF
PyroGenesis Canada
N/A$0.32
-1.8%
N/A-52.3%$59.70M$9.14M-5.3190
ATRA
Atara Biotherapeutics
4.6337 of 5 stars
$11.50
+15.0%
$20.00
+73.9%
+18.6%$59.61M$128.94M-3.09330News Coverage
Positive News
KLTO
Klotho Neurosciences
N/A$1.20
-7.0%
N/AN/A$59.41MN/A-3.33N/ANews Coverage
ARTV
Artiva Biotherapeutics
2.6687 of 5 stars
$2.55
+6.7%
$17.80
+598.0%
-69.8%$58.23M$250K0.0081
IFRX
InflaRx
2.4447 of 5 stars
$0.86
-0.8%
$6.60
+670.1%
-41.3%$58M$180K-1.0560
ADVM
Adverum Biotechnologies
4.5009 of 5 stars
$2.71
-2.2%
$23.80
+778.2%
-66.6%$57.87M$1M-0.42190News Coverage
Positive News
IZTC
Invizyne Technologies
N/A$9.25
flat
N/AN/A$57.83MN/A0.0029News Coverage
Gap Up
INMB
INmune Bio
1.9985 of 5 stars
$2.38
-1.7%
$18.40
+673.1%
-68.0%$57.08M$10K-1.2310Positive News
Upcoming Earnings
ABVC
ABVC BioPharma
0.6286 of 5 stars
$3.52
+5.1%
N/A+318.1%$56.89M$510K-27.0830
ALGS
Aligos Therapeutics
4.306 of 5 stars
$8.64
-5.7%
$70.00
+710.2%
-32.4%$56.01M$3.94M-0.4990News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:MTEX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners